Efficacy Testing of Melon Oil Olive Pressed Candy Products
- Conditions
- Skin Condition
- Interventions
- Dietary Supplement: melon and oil olive pressed candyDietary Supplement: Placebo candy
- Registration Number
- NCT05988567
- Lead Sponsor
- TCI Co., Ltd.
- Brief Summary
To assess melon and oil olive pressed candy on skin condition improvement
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Healthy adults aged above 18 years old
- ITA° value 20°-41°
- Involuntary subjects.
- Subjects who have a history of skin diseases such as psoriasis, eczema, atopic dermatitis, severe acne; or suffer from other chronic systemic disease.
- Those with known cosmetic, drug or food allergies.
- Female who is pregnant or nursing or planning to become pregnant during the course of the study.
- Subjects who have taken oral or topical corticosteroids and other anti-inflammatory drugs in the past 1 month.
- Use of any products or drugs that affect skin color such as fruit acid, salicylic acid (such as Hydroquinone preparations) in the past 2 months.
- In the past 3 months, the test site has used retinoic acid preparations or undergone chemical peeling, laser, pulse light and other medical aesthetic therapists
- Subjects who can not avoid long-term sun exposure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description melon and oil olive pressed candy melon and oil olive pressed candy - Placebo candy Placebo candy -
- Primary Outcome Measures
Name Time Method The change of skin wrinkles Change from Baseline skin wrinkles at 12 weeks VISIA Complexion Analysis System was utilized to measure skin wrinkles. Units: arbitrary units
The change of skin melanin index Change from Baseline skin melanin index at 12 weeks Mexameter® MX18 was utilized to measure skin melanin index. Units: arbitrary units
The change of skin erythema index Change from Baseline skin erythema index at 12 weeks Mexameter® MX18 was utilized to measure skin erythema index. Units: arbitrary units
The change of skin ITA° value Change from Baseline ITA° value at 12 weeks Chroma Meter MM500 was utilized to measure skin ITA° value. Units: arbitrary units
The change of skin texture Change from Baseline skin texture at 12 weeks VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
The change of skin b* value Change from Baseline b* value at 12 weeks Chroma Meter MM500 was utilized to measure skin b\* value. Units: arbitrary units
The change of skin L* value Change from Baseline L* value at 12 weeks Chroma Meter MM500 was utilized to measure skin L\* value. Units: arbitrary units
The change of skin spots Change from Baseline skin spots at 12 weeks VISIA Complexion Analysis System was utilized to measure skin spots. Units: arbitrary units
The change of skin UV spots Change from Baseline skin UV spots at 12 weeks VISIA Complexion Analysis System was utilized to measure skin UV spots. Units: arbitrary units
The change of skin brown spots Change from Baseline skin brown spots at 12 weeks VISIA Complexion Analysis System was utilized to measure skin brown spots. Units: arbitrary units
- Secondary Outcome Measures
Name Time Method The change of GSH-Px of blood Change from Baseline GSH-Px at 12 weeks Venous blood was sampled to measure GSH-Px
The change of SOD of blood Change from Baseline SOD at 12 weeks Venous blood was sampled to measure SOD
The change of TEAC of blood Change from Baseline TEAC at 12 weeks Venous blood was sampled to measure TEAC
Trial Locations
- Locations (1)
Chia Nan University of Pharmacy & Science
🇨🇳Tainan City, Taiwan